Menu

Xenon Pharmaceuticals Inc. XENE

Full chart Compare
Set alert

Price alert · XENE

All alert types
39.23 USD +0.06 (+0.15%)

Nov 9, 2026, 10:08 AM EST

38.59 Day range 39.74
33.38 52-week range 72.66
YTD
-12.47%
1 year
+2.56%

Revenue & Expenses

Other Income → Expenses: $28.18MOther Operating Income → Expenses: $2.54MExpenses → Selling, General & Admin: $79.63MExpenses → Research & Development: $300.94MExpenses → Income Tax: $1.02MGross Profit → Expenses: $4.96MRevenue → Gross Profit: $4.96MRevenue → Cost of Revenue: $2.54MNet Loss → Expenses: $345.91MOther Income$28.18MOther Operating Income$2.54MGross Profit$4.96MNet Loss$345.91MCost of Revenue$2.54MExpenses$381.59MSelling, General & Admin$79.63MResearch & Development$300.94MIncome Tax$1.02MRevenue$7.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

XENE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.50M009.43M18.44M
7.50M009.43M18.44M
7.50M009.43M18.44M
380.57M279.30M214.05M138.58M97.43M
300.94M210.39M167.51M105.77M75.46M
79.63M68.90M46.54M32.81M21.97M
-373.07M-279.30M-214.05M-129.14M-78.99M
1.02M-4.09M-292.00K118.00K-6.00K
-345.91M-234.33M-182.39M-125.37M-78.88M
-345.91M-234.33M-182.39M-124.94M-77.09M
-345.91M-234.33M-182.39M-124.94M-77.09M
-345.91M-234.33M-182.39M-125.37M-78.88M
-4.36-3.01-2.73-2.06-1.77
-4.36-3.01-2.73-2.06-1.77
-4.36-3.01-2.73-2.06-1.77
-344.89M-238.42M-182.69M-125.25M-78.89M
-344.89M-238.42M-182.69M-125.25M-78.89M
79.25M77.89M66.89M60.54M43.63M
79.25M77.89M66.89M60.54M43.63M